1.62
price down icon2.41%   -0.04
after-market Handel nachbörslich: 1.67 0.05 +3.09%
loading

Macrogenics Inc Aktie (MGNX) Neueste Nachrichten

pulisher
05:36 AM

MacroGenics appoints new CEO - MSN

05:36 AM
pulisher
05:27 AM

MacroGenics Slows Its Losses And Adds $70 Million To The Bank - Finimize

05:27 AM
pulisher
04:56 AM

MacroGenics Revenue Doubles in Q2 - The Globe and Mail

04:56 AM
pulisher
04:32 AM

MacroGenics Inc earnings missed by $0.11, revenue fell short of estimates - Investing.com

04:32 AM
pulisher
04:21 AM

MacroGenics Revenue Doubles in Q2 - The Motley Fool

04:21 AM
pulisher
04:18 AM

MacroGenics: Q2 Earnings Snapshot - San Francisco Chronicle

04:18 AM
pulisher
04:03 AM

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities - GlobeNewswire

04:03 AM
pulisher
04:01 AM

MacroGenics Extends Cash Runway to 2027 with $70M Royalty Deal as New CEO Unveils Strategic Roadmap - Stock Titan

04:01 AM
pulisher
12:28 PM

MacroGenics’ MGC026 Study: A New Hope for Advanced Solid Tumors? - TipRanks

12:28 PM
pulisher
07:07 AM

MacroGenics promotes Eric Risser to president and CEO - The Pharma Letter

07:07 AM
pulisher
01:39 AM

MacroGenics' Leadership Transition: A Strategic Inflection Point for Capital Efficiency and Growth - AInvest

01:39 AM
pulisher
Aug 13, 2025

Short Term Charts Align With Long Term Uptrend in MacroGenics Inc.July 2025 Intraday Action & Weekly Market Pulse Updates - beatles.ru

Aug 13, 2025
pulisher
Aug 13, 2025

MacroGenics Appoints Eric Risser As CEO - MarketScreener

Aug 13, 2025
pulisher
Aug 13, 2025

MacroGenics names Eric Risser as new CEO, succeeding Scott Koenig By Investing.com - Investing.com Nigeria

Aug 13, 2025
pulisher
Aug 13, 2025

MacroGenics Appoints Eric Risser as New CEO - TipRanks

Aug 13, 2025
pulisher
Aug 13, 2025

MacroGenics appoints Eric Risser as new CEO, succeeding Scott Koenig By Investing.com - Investing.com Australia

Aug 13, 2025
pulisher
Aug 13, 2025

MacroGenics Appoints Eric Risser as President and Chief Executive Officer - GlobeNewswire

Aug 13, 2025
pulisher
Aug 13, 2025

MacroGenics Taps Deal-Making Expert Eric Risser as CEO After 24-Year Leadership Run Ends - Stock Titan

Aug 13, 2025
pulisher
Aug 10, 2025

How liquid is MacroGenics Inc. stockBreakout Stocks for Quick Return - mustnews.co.kr

Aug 10, 2025
pulisher
Aug 07, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics, Inc. LawsuitMGNX - ACCESS Newswire

Aug 07, 2025
pulisher
Aug 03, 2025

What makes MacroGenics Inc. stock price move sharplyFast-track wealth growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about MacroGenics Inc. stockUnmatched profit growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is MacroGenics Inc. stock compared to the marketAccelerate your capital gains today - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does MacroGenics Inc. stock perform well during market downturnsInvest smarter with high-probability setups - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying MacroGenics Inc. stockDynamic investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for MacroGenics Inc.Unbelievable profit margins - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are MacroGenics Inc. company’s key revenue driversHigh-yield investments - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is MacroGenics Inc. a growth stock or a value stockSuperior return velocity - Jammu Links News

Aug 03, 2025
pulisher
Aug 01, 2025

How strong is MacroGenics Inc. company’s balance sheetEntry Signal Growth Plan For Every Investor - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics LawsuitMGNX - ACCESS Newswire

Aug 01, 2025
pulisher
Jul 31, 2025

MacroGenics’ Prostate Cancer Study: A Potential Game-Changer? - TipRanks

Jul 31, 2025
pulisher
Jul 31, 2025

MacroGenics' Prostate Cancer Study: Lorigerlimab's Potential Impact on Treatment Outcomes - AInvest

Jul 31, 2025
pulisher
Jul 29, 2025

Why MacroGenics Inc. stock attracts strong analyst attentionTriple Digit Return Stock Predictions Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment? - TipRanks

Jul 29, 2025
pulisher
Jul 29, 2025

RSI and MACD Indicate Shift in MacroGenics Inc. SentimentProven Entry Plan With Low Risk Shared - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Is MacroGenics Inc. Starting a New UptrendBuy Low Sell High Stock Watch Strategy in Focus - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

Will MacroGenics Inc. see short term momentumWeekly Trend Watch with Market Signals - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What the charts say about MacroGenics Inc. todayGrowth Summary Based on Market Positioning - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Analyzing MacroGenics Inc. with multi timeframe chartsFree Trend Following Strategy With Stop Loss - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How does MacroGenics Inc. generate profit in a changing economyAchieve breakthrough gains with expert advice - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive MacroGenics Inc. stock higher in 2025Invest confidently with real-time market updates - Jammu Links News

Jul 28, 2025
pulisher
Jul 27, 2025

What is MacroGenics Inc. company’s growth strategyRealize consistent double-digit growth - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

Why is MacroGenics Inc. stock attracting strong analyst attentionAchieve rapid wealth accumulation with smart picks - Jammu Links News

Jul 27, 2025
$36.50
price up icon 0.11%
$86.16
price up icon 0.36%
$26.45
price down icon 1.56%
$127.75
price up icon 3.97%
$112.70
price down icon 0.07%
biotechnology ONC
$309.69
price up icon 0.71%
Kapitalisierung:     |  Volumen (24h):